Please Scroll Down to See Forums Below 
1Mistake2006
New member
Well I know their Cialis works!!! hahahaha
JJ
JJ
fightining gyno! is ag.guys letro ligit?
- Thread starter markmark
- Start date
M
Mr.X
Guest
1Mistake2006 said:
who doesn't?
M
Mr.X
Guest
Mastagon said:
For estrogenic gyno, letro + nolva is awesome
Gynecomastia: effect of prolonged treatment with dihydrotestosterone by the percutaneous route
* Kuhn JM,
* Laudat MH,
* Roca R,
* Dugue MA,
* Luton JP,
* Bricaire H.
Gynaecomastia is a frequent disorder, sometimes painful or psychologically disturbing. Percutaneous dihydrotestosterone (DHT) was used to treat 30 patients with idiopathic gynaecomastia (IG) and 17 patients in whom the condition was associated with hypogonadism. All patients complaining of pain were relieved. Breast enlargement regressed or was substantially reduced in 22 of the IG patients and in all cases with hypogonadism, except those with gonadal dysgenesis. Plasma levels of testosterone and 17 beta-estradiol were significantly lowered in patients with IG as compared with controls. There was a significant increase in plasma DHT levels and in plasma androgen/estradiol ratio in all cases. The beneficial effects of the drug were manifest within 1 to 2 months in responsive patients. These effects may be due to a local and/or systemic activity. It is suggested that this medium-term treatment without side-effects should be tried in all cases of hypogonadism with gynaecomastia and in IG before considering more drastic therapeutic measures.
PMID: 6220269 [PubMed - indexed for MEDLINE]
---------------------------------------------------------
Successful percutaneous dihydrotestosterone treatment of gynecomastia occurring during highly active antiretroviral therapy: four cases and a review of the literature.
* Benveniste O,
* Simon A,
* Herson S.
Fourteen cases of gynecomastia occurring during highly active antiretroviral therapy (HAART) have been reported in the literature. To date, no specific therapeutic approach has been proposed, and gynecomastia has usually persisted. We report 4 new cases of HAART-induced gynecomastia that were successfully treated with percutaneous dihydrotestosterone gel.
PMID: 11512095 [PubMed - indexed for MEDLINE]
---------------------------------------------------------
Studies on the treatment of idiopathic gynaecomastia with percutaneous dihydrotestosterone.
* Kuhn JM,
* Roca R,
* Laudat MH,
* Rieu M,
* Luton JP,
* Bricaire H.
We have studied clinical and endocrine parameters in a group (group A) of forth men referred to us because of persistent idiopathic gynaecomastia (of more than 18 months duration), before and during the administration of percutaneous dihydrotestosterone (DHT). The endocrine parameters (testosterone (T), 17 beta-oestradiol (E2), DHT, gonadotrophins (FSH and LH) and prolactin (PRL), were compared to those of control groups of 12 healthy men on DHT therapy (group B) and 10 on placebo (group C). Local administration of DHT was followed by the complete disappearance of gynaecomastia in 10 patients, partial regression in 19 and no change in 11 patients after 4 to 20 weeks of percutaneous DHT (125 mg twice daily).
PMID: 6354523 [PubMed - indexed for MEDLINE]
---------------------------------------------------------
So is DHT, even by itself.
* Kuhn JM,
* Laudat MH,
* Roca R,
* Dugue MA,
* Luton JP,
* Bricaire H.
Gynaecomastia is a frequent disorder, sometimes painful or psychologically disturbing. Percutaneous dihydrotestosterone (DHT) was used to treat 30 patients with idiopathic gynaecomastia (IG) and 17 patients in whom the condition was associated with hypogonadism. All patients complaining of pain were relieved. Breast enlargement regressed or was substantially reduced in 22 of the IG patients and in all cases with hypogonadism, except those with gonadal dysgenesis. Plasma levels of testosterone and 17 beta-estradiol were significantly lowered in patients with IG as compared with controls. There was a significant increase in plasma DHT levels and in plasma androgen/estradiol ratio in all cases. The beneficial effects of the drug were manifest within 1 to 2 months in responsive patients. These effects may be due to a local and/or systemic activity. It is suggested that this medium-term treatment without side-effects should be tried in all cases of hypogonadism with gynaecomastia and in IG before considering more drastic therapeutic measures.
PMID: 6220269 [PubMed - indexed for MEDLINE]
---------------------------------------------------------
Successful percutaneous dihydrotestosterone treatment of gynecomastia occurring during highly active antiretroviral therapy: four cases and a review of the literature.
* Benveniste O,
* Simon A,
* Herson S.
Fourteen cases of gynecomastia occurring during highly active antiretroviral therapy (HAART) have been reported in the literature. To date, no specific therapeutic approach has been proposed, and gynecomastia has usually persisted. We report 4 new cases of HAART-induced gynecomastia that were successfully treated with percutaneous dihydrotestosterone gel.
PMID: 11512095 [PubMed - indexed for MEDLINE]
---------------------------------------------------------
Studies on the treatment of idiopathic gynaecomastia with percutaneous dihydrotestosterone.
* Kuhn JM,
* Roca R,
* Laudat MH,
* Rieu M,
* Luton JP,
* Bricaire H.
We have studied clinical and endocrine parameters in a group (group A) of forth men referred to us because of persistent idiopathic gynaecomastia (of more than 18 months duration), before and during the administration of percutaneous dihydrotestosterone (DHT). The endocrine parameters (testosterone (T), 17 beta-oestradiol (E2), DHT, gonadotrophins (FSH and LH) and prolactin (PRL), were compared to those of control groups of 12 healthy men on DHT therapy (group B) and 10 on placebo (group C). Local administration of DHT was followed by the complete disappearance of gynaecomastia in 10 patients, partial regression in 19 and no change in 11 patients after 4 to 20 weeks of percutaneous DHT (125 mg twice daily).
PMID: 6354523 [PubMed - indexed for MEDLINE]
---------------------------------------------------------
So is DHT, even by itself.
M
Mr.X
Guest
whoa, a study lol....I'm rubbing some DHT on my chest right now
